Heron Therapeutics Inc (NASDAQ: HRTX) is -30.00% lower on its value in year-to-date trading and has touched a low of $0.72 and a high of $3.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HRTX stock was last observed hovering at around $1.24 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $1.19, the stock is -29.27% and -34.72% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.5 million and changing -4.03% at the moment leaves the stock -53.45% off its SMA200. HRTX registered 38.37% gain for a year compared to 6-month loss of -62.81%. The firm has a 50-day simple moving average (SMA 50) of $1.8228 and a 200-day simple moving average (SMA200) of $2.5566.
The stock witnessed a -34.62% gain in the last 1 month and extending the period to 3 months gives it a -39.90%, and is -32.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.23% over the week and 8.61% over the month.
Heron Therapeutics Inc (HRTX) has around 126 employees, a market worth around $173.20M and $137.74M in sales. Profit margin for the company is -20.30%. Distance from 52-week low is 65.28% and -69.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-20.72%).
with sales reaching $37.37M over the same period.The EPS is expected to grow by 83.75% this year, but quarterly earnings will post 18.76% year-over-year. Quarterly sales are estimated to grow 9.15% in year-over-year returns.
Heron Therapeutics Inc (HRTX) Top Institutional Holders
219.0 institutions hold shares in Heron Therapeutics Inc (HRTX), with institutional investors hold 82.18% of the company’s shares. The shares outstanding are 150.29M, and float is at 144.08M with Short Float at 20.00%. Institutions hold 81.60% of the Float.
The top institutional shareholder in the company is RUBRIC CAPITAL MANAGEMENT LP with over 26.71 million shares valued at $93.5 million. The investor’s holdings represent 17.6678% of the HRTX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 8.62 million shares valued at $30.16 million to account for 5.6984 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 8.33 million shares representing 5.5062% and valued at over $29.14 million, while ADAGE CAPITAL PARTNERS GP, L.L.C. holds 5.0265 of the shares totaling 7.6 million with a market value of $26.6 million.
Heron Therapeutics Inc (HRTX) Insider Activity
#####
